SavedAdd your journal

Journals / Eurasian Journal of Medicine / 2011 / Cilt: 43 - Sayı: 3

Heparin tedavisinin kesilmesinden sonra gelişen beyin sapı infarkt olguları: bir rebaund etki olabilir mi?

Cases of brainstem infarcts after cessation of heparin treatment: is it a rebound effect?

Fidan SÜRGÜN
Caner Feyzi DEMİR
Oktay KAPAN
Hasan ÖZDEMİR
Pages
186–188
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Others risk factors were analyzed, and the discontinuation of heparin infusion was also considered to have a predominant role in the development of infarction.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The presented cases represent patients with acute coronary syndrome treated with heparin infusion who developed brainstem infarction after discontinuation of heparin treatment.
📊
Key Findings & Data:The patients did not present genetic coagulopathy.
💡
Conclusion & Impact:Others risk factors were analyzed, and the discontinuation of heparin infusion was also considered to have a predominant role in the development of infarction.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The presented cases represent patients with acute coronary syndrome treated with heparin infusion who developed brainstem infarction after discontinuation of heparin treatment. The patients did not present genetic coagulopathy. Others risk factors were analyzed, and the discontinuation of heparin infusion was also considered to have a predominant role in the development of infarction.

Özet

Akut koroner sendrom tanısı ile heparin tedavisi almakta olan ve heparin tedavisi kesildikten sonra beyin sapı infarktı gelişen iki olgu sunuldu. Hastalarda genetik koagülopati saptanmadı. Diğer risk faktörleri analiz edildi ve heparin infüzyonunun kesilmesinin de infarkt gelişiminde öncül bir rolü olabileceği düşünüldü.

🔖

Cite This Article

SÜRGÜN, F., DEMİR, C. F., KAPAN, O., ÖZDEMİR, H. (2022). Heparin tedavisinin kesilmesinden sonra gelişen beyin sapı infarkt olguları: bir rebaund etki olabilir mi?. Eurasian Journal of Medicine, Cilt: 43 - Sayı: 3, 186–188. https://ajindex.com/articles/509269

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Shah AM, Banerjee T, Mukherjee D. Coronary, peripheral and cerebrovascular disease: a complex relationship. J Indian Med Assoc 2010; 108: 292-6. 2.Kumral E, Bayulkem G, Evyapan D. Clinical spectrum of pontine infarction: Clinical-MRI correlations, J Neurol 2002; 249: 1659-70. 3. Bahit MC, Topol EJ, Califf RM, et al. Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromes. J Am Coll Cardiol 2001; 37: 1001-7. 4. Lauer MA, Houghtaling PL, Peterson JG, et al. Platelet IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators. Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb/ IIIa inhibition with eptifibatide in patients with acute coronary syndromes: observations from the platelet IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial. Circulation 2001; 104: 2772-7. 5. Xiao Z, Theroux P. Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor. Circulation 1998; 97: 251-6.